Biotech industry welcomes EU's "Innovation Union"
This article was originally published in Scrip
The biotech industry has welcomed the European Commission's announcement of plans to establish an "Innovation Union" in the EU by 2020 that will focus on areas such as health, the ageing population and climate change.
You may also be interested in...
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
The new EU commissioner for health has been given a number of high-priority tasks, including medicines supply and tackling antimicrobial resistance. These topics will be taken up by the European Commission’s advisory body, the Pharmaceutical Committee, in its new work plan.
Two EU bodies want to move forward with European Commission proposals on contamination of the environment by pharmaceutical substances.